Hydroxylamines

DBCAT000393Pharmacologic class

Organic compounds that contain the (-NH2OH) radical. A DrugBank category of 73 drugs. 14 of them are approved.

Drugs: 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
4-Phospho-D-erythronohydroxamic acid
6-bromoindirubin-3'-oxime
Abexinostat
Acetohydroxamic acid
Adrafinil
Alilusem
Aminooxyacetic acid
Ancriviroc
Asoprisnil
Bb-3497
Belinostat
Beloxamide
Benurestat
Benzhydroxamic Acid
Brasofensine
Bufexamac
Caprylhydroxamic acid
CGS-27023
Clovoxamine
Coprogen
CTS-1027
CUDC-101
Dabrafenib
Dacinostat
and 48 more with a free account

What you can answer from here — as of August 24, 2016

73DrugsEach linked to its full drug card

123Drug targetsEvery drug–target pair in the class, with bond type

396Marketed productsAcross the regions we cover, with dosage forms and routes

10Routes of administrationHow the drugs in this class are given

Which targets do Hydroxylamines share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In